Buy 2 ASX shares for cutting-edge tech changing the world: expert

Wilson analyst picks a pair of stocks that are using amazing technologies to produce innovative solutions to global problems.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite the tyranny of distance from the rest of the world, or perhaps because of it, Australia has produced its fair share of innovations.

There are, in fact, companies listed on the ASX right now that are working on sophisticated, market-leading technologies that could one day improve the lives of many around the world.

This week Wilson Asset Management analysts identify two such ASX shares that they recommend as a buy: 

A woman looks internationally at a digital interface of the world.

Image source: Getty Images

Helping people heal from terrible injuries

ASX biotechnology shares have taken an absolute pummeling over the past 12 months.

But equities dealer Will Thompson is high on Aroa Biosurgery Ltd (ASX: ARX).

"Aroa develops, manufactures and distributes medical products," he said in a WAM video.

"Their product is, with the fear of oversimplifying it, just a really high-quality Band-Aid, which you'd use if you were in a bad motorcycle crash and you lost quite a bit of skin."

The concept itself is mature, but Aroa's product is different from incumbents as it is made organically.

"Next year there's a few regulation changes, which could really benefit it."

In a horrible year for its peers, the Aroa share price is actually 7% higher than where it started 2022. The ASX share has rocketed up an eye-popping 44% since the start of October.

According to Thompson, Aroa has already put some runs on the board.

"It recently posted some storing sales numbers and actually showed that there's some cash generation as well," he said.

"Next year's going to be a big year for them, so it's a buy."

Helping resist global warming

Because of the bearish nature of markets this year, new ASX listings were few and far between.

LGI Ltd (ASX: LGI), which floated in October, is a rare example of a 2022 debutant that isn't in the resources sector.

Thompson explained that LGI is a gas abatement provider.

"Where all your rubbish and landfill goes, they take the methane out of that area," he said.

"Methane's 26 times worse for the environment than carbon dioxide. They turn that into energy, which they supply back into the market."

Therefore the business takes in revenue from both power generation and carbon credits.

"They're doing some really interesting investments where they think they can probably increase profitability by putting a battery in the system. So that's where the capital's going."

The initial public offer saw IGL shares sold at $1.50 per share. The stock closed Thursday at $1.97.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »